Skip to content
Cardurion Pharmaceuticals logo

Cardurion Pharmaceuticals Alternatives & Competitors

4 companies similar to Cardurion Pharmaceuticals — Translating the science of cardiac myocyte signaling pathways into groundbreakin...

Companies similar to Cardurion Pharmaceuticals

Pharmacopeia logo — alternative to Cardurion Pharmaceuticals

Pharmacopeia

Innovating to meet critical health challenges with advanced therapeutic discoveries and de...

InterCure logo — alternative to Cardurion Pharmaceuticals

InterCure

Harness the power of respiratory-based treatment for hypertension and heart failure with i...

Lixte Biotechnology Holdings, Inc. logo — alternative to Cardurion Pharmaceuticals

Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology (Nasdaq: LIXT)

Santaris Pharma logo — alternative to Cardurion Pharmaceuticals

Santaris Pharma

Pioneering RNA-targeted therapies with rapid LNA-based drug development for diverse diseas...

About Cardurion Pharmaceuticals

Cardurion Pharmaceuticals, founded in 2017, is a biotechnology and pharmaceutical company targeting advancements in cardiovascular health through innovative drug discovery. The company is renowned for its expertise in translating cardiac myocyte signaling pathways into groundbreaking therapeutics, specifically focusing...

Services

Research and Development of Cardiovascular Drugs, Clinical Programs in PDE9 and CaMKII, In-house Drug Discovery, Clinical Study Evaluation

Target Customers

Patients with Cardiovascular Disease, Healthcare Providers, Pharmaceutical Companies, Biotechnology Investors

Business keywords

Cardurion Pharmaceuticals, Cardiac Myocyte Signaling Pathways, PDE9 Inhibition, CaMKII Inhibition, Cardiovascular Therapeutics, Heart Failure Treatment, Biotechnology Company, Clinical Programs, Cardiovascular Diseases, Partnerships, Investors, Bain Capital, Takeda Pharmaceutical, Astellas, Drug Discovery, Boston-based Company

Frequently Asked Questions

Companies similar to Cardurion Pharmaceuticals include Pharmacopeia, InterCure, Lixte Biotechnology Holdings, Inc., Santaris Pharma. They work in Biotechnology and Pharmaceutical and share Cardurion Pharmaceuticals's focus on cardiovascular diseases and drug discovery.
Bounce Watch lists 4 companies that share Cardurion Pharmaceuticals's industries and are closest to it in business tags, services, target customers, business model and size.
Cardurion Pharmaceuticals, founded in 2017, is a biotechnology and pharmaceutical company targeting advancements in cardiovascular health through innovative drug discovery. The company is renowned for its expertise in translating cardiac myocyte signaling pathways into groundbreaking therapeutics, specifically focusing...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Cardurion Pharmaceuticals: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Cardurion Pharmaceuticals on 12 Sep 2024. The 4 companies listed here were last checked between 26 Jul 2024 and 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout